JakeNathanielLichtermanDO
Internal Medicine • Dallas, TXHematology/Oncology
Instructor, GU medical oncologist, Immuno-oncology basic/translational researcher
Dr. Lichterman is on Doximity
As a Doximity member you'll join over two million verified healthcare professionals in a private, secure network.
- Gain access to free telehealth tools, such as our “call shielding” and one-way patient texting.
- Connect with colleagues in the same hospital or clinic.
- Read the latest clinical news, personalized to your specialty.
Office
5323 Harry Hines Boulevard
Dallas, TX 75390Phone+1 214-645-0272Fax+1 214-648-7121
Education & Training
University of Texas Southwestern Medical CenterFellowship, Hematology and Medical Oncology, 2020 - 2024- University of Texas Southwestern Medical CenterResidency, Internal Medicine, 2018 - 2020
Touro College of Osteopathic MedicineClass of 2018
Certifications & Licensure
TX State License 2020 - 2026- American Board of Internal Medicine Internal Medicine
Publications & Presentations
PubMed
- 39 citationsImmune checkpoint blockade induces gut microbiota translocation that augments extraintestinal antitumor immunity.Yongbin Choi, Jake N Lichterman, Laura A Coughlin, Nicole Poulides, Wenling Li
Science Immunology. 2023-03-10 - 83 citationsA comparison of isolated circulating tumor cells and tissue biopsies using whole-genome sequencing in prostate cancerRunze Jiang, Yi-Tsung Lu, Hao Ho, Bo Li, Jie-Fu Chen
Oncotarget. 2015-11-14 - 82 citationsSubclassification of prostate cancer circulating tumor cells by nuclear size reveals very small nuclear circulating tumor cells in patients with visceral metastases.Jie-Fu Chen, Hao Ho, Jake Lichterman, Yi-Tsung Lu, Yang Zhang
Cancer. 2015-09-15
Viewing the full profile is available to verified healthcare professionals only.
Find your profile and take control of your online presence:
